GRIFOLS SA
GRFS8.2000.61% ( +0.050 )
GRIFOLS SA (GRFS)
Grifols, S.A., together with its subsidiaries, engages in the research, development, production, and marketing of plasma-derived medicines in the United States,...
- Open
- 8.320
- High
- 8.370
- Low
- 8.135
- Prev. Close
- 8.150
- Volume
- 1.13M
- Turnover
- 9.30M
- Avg Price
- 8.247
- Bid/Ask Ratio
- --
- Amplitude
- 2.88%
- 52wk High
- 10.792
- Volume Ratio
- 1.16
- Turnover Ratio
- 0.27%
GRIFOLS SA Analyst Rating
View MoreForecast & Rating
Jul 29, 2026Price forecast
$10.8732.50%
Forecast & RatingBuy
2analysts
- Strong buy50.00%
- Buy0.00%
- Hold50.00%
- Sell0.00%
- Strong sell0.00%
News
- Tip Ranks · 20 hours ago
Grifols Reshapes Board and Committee Leadership After Director Resignation
- PUBT · 1 day ago, 01:53 AM
Grifols names Joanna Susan Le Couilliard as audit committee chair
- Motley Fool · 2 days ago, 07:54 PM
Grifols (GRFS) Q2 2026 Earnings Call Transcript
- Quartr · 2 days ago, 01:40 PM
GRF: Biopharma and IG growth drove higher revenue and margins, supporting 2026 guidance
- Market Beat · 2 days ago, 01:04 PM
Grifols Q2 Earnings Call Highlights
- Quartr · 2 days ago, 10:46 AM
GRF: Revenue up 2.6% and net profit up 28.7%, driven by Biopharma and strong IG growth
